Clinical Trial Update: Magnesium Isoglycyrrhizinate Followed by Diammonium Glycyrrhizinate and Combined With Entecavir in Chronic Hepatitis B [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on a combination therapy consisting of magnesium isoglycyrrhizinate, diammonium glycyrrhizinate, and entecavir for chronic hepat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Liver Inflammation

Drugs mentioned

• Diammonium glycyrrhizinate (Diammonium glycyrrhizinate)
• ENTECAVIR (ENTECAVIR)
• Magnesium isoglycyrrhizinate (magnesium isoglycyrrhizinate)

Snippet

Sponsor: Cttq | Conditions: Chronic Hepatitis b, Liver Inflammation | Phase 4 | Status: UNKNOWN